Alberto Broniscer
St Jude Children's Research Hospital
Memphis
USA
Name/email consistency: high
- Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. Broniscer, A., Baker, J.N., Tagen, M., Onar-Thomas, A., Gilbertson, R.J., Davidoff, A.M., Pai Panandiker, A.S., Panandiker, A.P., Leung, W., Chin, T.K., Stewart, C.F., Kocak, M., Rowland, C., Merchant, T.E., Kaste, S.C., Gajjar, A. J. Clin. Oncol. (2010)
- Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma. Broniscer, A., Baker, S.J., Stewart, C.F., Merchant, T.E., Laningham, F.H., Schaiquevich, P., Kocak, M., Morris, E.B., Endersby, R., Ellison, D.W., Gajjar, A. Clin. Cancer Res. (2009)
- Young age may predict a better outcome for children with diffuse pontine glioma. Broniscer, A., Laningham, F.H., Sanders, R.P., Kun, L.E., Ellison, D.W., Gajjar, A. Cancer (2008)
- Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report. Broniscer, A., Gururangan, S., MacDonald, T.J., Goldman, S., Packer, R.J., Stewart, C.F., Wallace, D., Danks, M.K., Friedman, H.S., Poussaint, T.Y., Kun, L.E., Boyett, J.M., Gajjar, A. Clin. Cancer Res. (2007)
- Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420. Broniscer, A., Panetta, J.C., O'Shaughnessy, M., Fraga, C., Bai, F., Krasin, M.J., Gajjar, A., Stewart, C.F. Clin. Cancer Res. (2007)
- Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. Broniscer, A., Baker, S.J., West, A.N., Fraser, M.M., Proko, E., Kocak, M., Dalton, J., Zambetti, G.P., Ellison, D.W., Kun, L.E., Gajjar, A., Gilbertson, R.J., Fuller, C.E. J. Clin. Oncol. (2007)
- Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. Broniscer, A., Chintagumpala, M., Fouladi, M., Krasin, M.J., Kocak, M., Bowers, D.C., Iacono, L.C., Merchant, T.E., Stewart, C.F., Houghton, P.J., Kun, L.E., Ledet, D., Gajjar, A. J. Neurooncol. (2006)
- Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma. Broniscer, A., Laningham, F.H., Kocak, M., Krasin, M.J., Fouladi, M., Merchant, T.E., Kun, L.E., Boyett, J.M., Gajjar, A. Cancer (2006)
- Past, present, and future strategies in the treatment of high-grade glioma in children. Broniscer, A. Cancer Invest. (2006)
- Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Broniscer, A., Iacono, L., Chintagumpala, M., Fouladi, M., Wallace, D., Bowers, D.C., Stewart, C., Krasin, M.J., Gajjar, A. Cancer (2005)
- Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist. Broniscer, A., Gajjar, A. Oncologist (2004)
- Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude Children's Research Hospital experience. Broniscer, A., Ke, W., Fuller, C.E., Wu, J., Gajjar, A., Kun, L.E. Cancer (2004)
